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ess: francesco.blasi@unSummary We analyzed 795 sputa from 315 patients (233 males, mean age 69.378.8
years, mean number of exacerbations 2.52/patient) with acute exacerbations of
moderate-to-severe chronic obstructive pulmonary disease (COPD) (mean steady-state
FEV1 42.577.8% of predicted). 581/795 sputa were considered adequate. Sputum was
analyzed by a quali-quantitative colorimetric scale allowing both color distinction and
color degree of intensity. Quantitative culture was then performed (threshold:
4106CFU/mL). Samples were distinguished in mucoid (145) and purulent (436) sputa.
Absence of bacterial growth was observed in 22% and 5% of mucoid and purulent sputa,
respectively. Among mucoid sputa, Gram positive bacterial growth occurred more
commonly compared to Gram negative and Pseudomonas aeruginosa/Enterobacter-
iaceae (56%, 24%, 20%, respectively). In purulent sputa, Gram positives were found in
38% of cases, Gram negatives in 38%, and P. aeruginosa/Enterobacteriaceae in 24%. We
evaluated whether functional impairment (FEV1) orientates as to the infectious
etiology of exacerbations. Significant differences were observed in the distribution of
pathogens. Gram negative and P. aeruginosa/Enterobacteriaceae were isolated more
frequently in the sputum when FEV1 was o35%. Our study indicates that purulent
sputum is strongly associated with bacterial growth in COPD exacerbations. Deepening
sputum color (from yellowish to brownish) was associated with increased yield of Gram
negative and P. aeruginosa/Enterobacteriaceae.
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Chronic obstructive pulmonary disease (COPD) is a
common respiratory disease associated with sub-
stantial health burden worldwide. It is estimated
that COPD affects at least 52 million worldwide,
and accounted for 2.74 million deaths in the year
2000.1 The natural history of the disease is one of
progressive decline punctuated with varying fre-
quency by exacerbations of symptoms.2 Available
data suggest that patients have such exacerbations
at a median rate of 2–3 episodes per year.3
There is no consistent definition of an acute
exacerbation of chronic bronchitis (AECB), but
these events generally include some, or all,
features such as increased dyspnea, wheeze,
cough, sputum volume, sputum purulence, chest
tightness, hypoxemia and hypercapnia. The best
known clinical definition was that proposed by
Anthonisen et al.,4 who identified increased sputum
volume, sputum purulence and dyspnea as cardinal
manifestations of AECB.
The causes triggering an acute exacerbation are
generally multifactorial and commonly include a
combination of smoking habits, environmental
irritants and infection.5 It is thought that up to
70% of infectious cases are caused by bacteria, the
remainder being attributable to ‘‘atypical’’ patho-
gens such as viruses, Mycoplasma pneumoniae, and
Chlamydia pneumoniae.6 Therefore, the use of
antibiotic therapy in the management of exacerba-
tions seems a rational choice in a certain number of
cases, although the matter is still debated. A meta-
analysis of randomized, placebo-controlled trials of
patients on antibiotic treatment in AECB demon-
strated a small but statistically significant improve-
ment attributable to antimicrobial therapy.7
Various attempts have been made to correlate
exacerbation characteristics with putative bacter-
ial pathogens. Miravitlles et al. have shown that
microrganisms causing acute exacerbations of
COPD are distributed unevenly among patients with
different degrees of disease severity, with patients
more severely affected showing a greater incidence
of Pseudomonas aeruginosa and Haemophilus in-
fluenzae.8 Sethi et al. associated increased neu-
trophil airway inflammation, as assessed by IL8,
TNF-a, and neutrophil elastase, with isolation of
bacteria in sputum of chronic bronchitis patients.9
Recently, Stockley et al. devised a sputum color
chart in order to distinguish between purulent and
mucoid COPD exacerbations.10 The underlying
principle was that the presence of bacteria causing
infection in the airways would be associated with
neutrophil recruitment, thus correlating with the
degree of yellow-green coloration of the sputumdue to neutrophil myeloperoxidase accumulation.
The authors found that the presence of green
(purulent) sputum was specific for a high bacterial
load in the airways, indicating a subset of patients
that would most likely benefit from antibiotic
therapy.
Aim of the present study was to determine
whether sputum color can provide an orientation
as to the infectious etiology of COPD exacerbations.
We also investigated the possible associations
between the degree of functional impairment, as
measured by FEV1, and presence of bacterial
pathogens in the airways.Materials and methods
Between 1997 and 2002 we considered patients
with COPD exacerbations referring to our institu-
tions. All had a clinical history of chronic bronchitis
(daily sputum production for at least 3 months of 2
consecutive years), patients with a past history of
bronchiectasis were excluded. We analyzed 795
sputa from 315 patients (233 males, mean age
69.378.8 years) with acute exacerbations of
moderate-to-severe COPD (mean steady-state
FEV1 42.577.8% of predicted). Patients were
placed in either the FEV1 50–35% category (257
patients), or the FEV1o35% (58 patients). Acute
exacerbation was defined by increased dyspnea,
cough, sputum volume, and sputum purulence as
reported by the patients. Patients were excluded
if they had received antibiotic treatment during
the previous 4 weeks. On the day of consultation,
demographic details, steady-state spirometry
and post-bronchodilator FEV1 values (obtained
within the previous 6 months) were recorded
from the clinical chart. In 477/795 episodes,
patients were hospitalized. Written informed con-
sent was obtained from all patients. The study
was approved by the University of Milan Ethical
Review Board.
A fresh sputum sample was obtained in a sterile
container, as free from saliva as possible. Gram
stain was performed, and sputum validity was
assessed by means of the Bartlett criteria. Quanti-
tative sputum culture was then performed (posi-
tivity threshold: 4106 CFU/mL).
In addition, sputum was analyzed by a quali-
quantitative colorimetric scale (patent no.
00218892/1994) characterized not only by color
distinction but also by degree of intensity. Sputum
samples were compared with the colors of a
multicolor ‘‘ink catalogue’’ (gamma ‘‘Pantone’’).
All colors in sputum samples were in the catalogue.
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Figure 1 Colorimetric scale for sputum color and
purulence evaluation (patent no. 00218892/1994).
L. Allegra et al.744Only for the definition of ‘‘white’’ in mucous
sputum was it necessary to resort to a blend of
colors. We identified about 50 different colors,
including shades or tones of individual colors. For
practical reasons we selected 10 reference colors
together with a ‘‘physiological’’ white. In addition
to being the most commonly occurring colors, the
10 selected specimens were used as reference
‘‘average’’ colors for other shades and tones.
Sputum samples were collected in a funnel. A
colorimetric scale was let slide under the funnel,
thereby allowing the approximate color identifica-
tion. Each color is coded with a number, which
can later be compared with other sputum samples
(Fig. 1). Samples with white or gray preponderance
(numbers 0 and 1, respectively) were considered as
mucoid, whereas shades of yellow, green, and
brown were considered as purulent (numbers
2–9). In a subgroup of the first 100 patients
enrolled, we compared sputum color assessment
provided by the patient and one of the investiga-
tors (PLD) using, as gold standard, the colorimetric
scale.
Statistical analysis
Statistical differences between groups were deter-
mined by the Student t-test for unpaired data.Results
Sputum characteristics and bacterial growth
Sputum samples were considered adequate in 581/
795 exacerbations (73%) according to the Bartlett
criteria. Samples were distinguished in mucoid
(145) and purulent (436) sputa.Absence of bacterial growth was observed in 32/
145 (22%) and 22/436 (5%) of mucoid and purulent
sputa, respectively ðPo0:001Þ: Among mucoid
sputum samples (color grading 0–1), Gram positive
bacterial growth occurred more commonly com-
pared to Gram negative and P. aeruginosa/Enter-
obacteriaceae (62.9% (Streptococcus pneumoniae
86%, Streptococcus spp. 11%, Staphylococcus aur-
eus 3%), 18.8% (H. influenzae 30% M. catarrhalis
70%), and 18.2%, respectively). In purulent sputa,
Gram positive bacteria were found in 44.6% of cases
in yellowish sputa (color grading 2–4) (S. pneumo-
niae 85%, S. aureus 10%, Streptococcus spp 5%),
in 22.6% in greenish sputa (color grading 5–7)
(S. pneumoniae 92% S. aureus 4%, Streptococcus
spp. 4%), and in 18.9% in brownish sputa (color
grading 8–9) (S. pneumoniae 42% S. aureus 58%).
Gram negatives were isolated in 49.9% of cases in
yellowish sputa (H. influenzae 70%, H. parainfluen-
zae 10%, M. catarrhalis 20%), in 39% in greenish
sputa (H. influenzae 53%, H. parainfluenzae 15%,
M. catarrhalis 32%), and in 37.8% in brownish
sputa (H. influenzae 64%, H. parainfluenzae 16%,
M. catarrhalis 20%).
P. aeruginosa/Enterobacteriaceae were found in
5.4% of cases in yellowish sputa, in 38.3% in
greenish sputa, and in 43.2% in brownish sputa.
Considering sputum purulence and isolated bacter-
ia, Gram positive bacteria isolation was signifi-
cantly associated with mucoid sputum ðPo0:001Þ:
Conversely, Gram negative and particularly Pseu-
domonas/Enterobacteriaceae isolation was asso-
ciated with purulent sputum ðPo0:001Þ: Moreover,
Pseudomonas/Enterobacteriaceae isolation was
significantly associated with higher color grading
(45; from green to brown) ðPo0:001Þ: Table 1
shows the correlation between sputum color and
bacterial growth.Lung function
Significant differences were observed in the dis-
tribution of pathogens on the basis of the degree of
functional impairment. Gram negative and P.
aeruginosa/Enterobacteriaceae were isolated more
frequently ðPo0:001Þ in the sputum of individuals
with FEV1o35% (Fig. 2).Color evaluation
The definition of sputum color by patients and
investigators was concordant in 68% of the cases,
without the aid of the color stick. When this first
judgment was compared to evaluation with the
color stick, patient and investigator definitions
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Figure 2 Bacterial growth according to purulence and
pulmonary function (FEV1% of predicted), in 581 sputum
specimens (845 isolates) obtained from 335 COPD
patients suffering from 795 exacerbations.
Sputum color as a marker of acute bacterial exacerbations of chronic obstructive pulmonary disease 745were confirmed only in 41% and 45% of the cases,
respectively. Discrimination of whitish, grayish,
yellowish, and brownish color shades was complex,
both for patients and investigators. In practice
these shades were employed interchangeably. In
addition, significant overestimations were found
for the definition of greenish (patient-color
stick ¼ 10:1; investigator-color stick 11:1) and
brownish (patient-color stick 8:1; investigator-
color stick 3:1) (Table 2).Discussion
In recent years, a greater insight has been achieved
in our knowledge on the inflammatory processes
involved in exacerbations, and on the relevance of
bacterial colonization in disease progression. A
major finding in the airway secretions of patients
with AECB is an increase in neutrophil accumula-
tion, high granulocyte/macrophage colony stimu-
lating factor, and increased markers of neutrophil
activation such as myeloperoxidase.11,12 There
appears to be a hierarchical contribution of
chemoattractants, with LTB4 being the first to
change at low levels of neutrophil influx (mild
exacerbations), and IL-8 becoming involved as
neutrophil influx and activation becomes more
intense in more severe exacerbations.13
In a subset of COPD patients with mild exacer-
bations prominent eosinophilia was found both inthe airway wall and the airway lumen.14 The
postulated mechanism for eosinophil recruitment
is an increase in TNF-a production which activates
epithelial cells and sub-epithelial lymphocytes to
produce the chemokine RANTES.15
Sputum purulence is one of the potential markers
of bacterial infection during exacerbations. Recent
studies indicate that purulence is associated with
significant bacterial growth and high microbial
load. Conversely, the bacterial nature of ‘‘mucoid’’
exacerbation has been questioned. In fact, Stockley
et al.10 reported that mucoid sputum yielded
positive bacterial culture in 38% of 34 exacerba-
tions whereas purulent sputum culture resulted
positive in 84% of 87 exacerbations. Moreover, in
mucoid exacerbations the bacterial load was low
and only two patients deteriorated without anti-
biotics. When patients were restudied in a stable
clinical state the sputum characteristics were
unchanged.
Our study indicates that purulent sputum ob-
tained during exacerbation is almost invariably
associated with bacterial growth in patients with
moderate-severe COPD. Furthermore, deepening
sputum color (from yellowish to brownish) is
associated with increased yield of Gram negative
and P. aeruginosa/Enterobacteriaceae. These bac-
teria are also more common in patients with most
severe functional impairment.
Color definition according to a colorimetric stick
provides a better approximation than patient or
investigator color descriptions such as ‘‘yellowish’’,
‘‘whitish’’, or ‘‘greenish’’, etc. We found that
patients are often very imprecise in identifying
colors; what is described as yellow is often, in fact,
green, and white is often actually gray. We were
able to overcome this difficulty by furnishing an
‘‘official’’ reference color by sliding a colorimetric
stick along the tube containing the specimen being
examined and reading the number corresponding to
that color.
Compared to data in the paper by Stockley
et al.10, we recorded a very high culture positivity
results both in mucoid and purulent sputa. Possible
explanations may be that the patient populations
in the two studies were not fully comparable since
participants in our study showed a higher degree
of functional impairment, and that a significant
proportion required hospitalization for their ex-
acerbation. Moreover, out of the total number
of sputa, 92.6% were cultured in the study by
Stockley et al. compared to 73% in our study.
This might be due to more selective screening
criteria in our population and may be associated
with a higher probability of observing positive
bacterial growth.
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Table 1 Correlation between sputum color grading and bacterial growth in sputum specimens in 581/795 COPD
exacerbations (335 patients).
Sputum color grading (581 sputum samples/845 isolates)
Bacterial growth 0–1 (white-gray)
(145 samples /170
isolates)
2–4 (yellowish) (322
samples/ 479
isolates)
5–7 (greenish) (93
samples/ 159
isolates)
8–9 (brownish) (21
samples/37 isolates)
Gram positive 107 (62.9%) 214 (44.6%) 36 (22.6%) 7 (18.9%)
[#S. pneumoniae/S.
spp./S. aureus]
[92/12/3] [182/9/21] [32/2/2] [3/-/4]
Gram negative 32 (18.8%) 239 (49.9%) 62 (39%) 14 (37.8%)
[#H. influenzae/H.
parainfluenzae/M.
catarrhalis]
[10/-/22] [167/24/48] [33/9/20] [9/2/3]
P. aeruginosa/
Enterobacteriaceae
31 (18.2%) 26 (5.4%) 61 (38.3%) 16 (43.2%)
No bacterial growth
[54/581 (9.2%)
sputum samples]
32/145 (22%) 10/322 (2.1%) 7/93 (7.5%) 5/21 (23.8%)
0–1: one isolate 48%; two isolates 23%; three isolates 7%.2–4: one isolate 50%; two isolates 34%; three isolates 11%.5–7: one
isolate 52%; two isolates 21%; three isolates 20%.8–9: one isolate 24%; two isolates 76%.
Table 2 Sputum color grading assessment by investigator and patients compared to colorimetric scale (100
samples).
Whitish/grayish Yellowish Greenish Brownish
Investigator/colorimetric scale 18/25 (72%) 22/44 (50%) 2/22 (9%) 3/9 (33%)
Patient/colorimetric scale 19/25 (76%) 21/44 (47%) 2/20a (10%) 1/8b(1.2%)
aTwo samples not analyzed.
bOne sample not analyzed.
L. Allegra et al.746Our data indicate that patient and investigator
judgment of color shade definition is unsatisfactory,
leading to underestimation of darker shades of
sputum coloration compared to the reference color
stick. This suggests that use of a colorimetric stick
may be important in order to correctly identify
patients that show a higher probability of harboring
Gram negative bacteria in their airways.
In summary, our study indicates that purulent
sputum is almost invariably associated with bacter-
ial growth in patients with COPD exacerbations.
Furthermore, deepening sputum color (from yel-
lowish to brownish) is associated with increased
yield of Gram negative and P. aeruginosa/Enter-
obacteriaceae. These bacteria are more common in
patients with most severe functional impairment.Acknowledgements
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